IRST - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Meldola 47014

1 studies enrolling now · 2 studies all time

What they study most

Refractory Hematologic Malignancy, Refractory Primary Central Nervous System Lymphoma, Relapsed Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations

Studies at this site

• CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) — Recruiting now
• Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML — Completed